Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

114

Full text

Free full text

Publication Types

Journal Article

112

Review

Research Support, Non-U.S. Gov't

Multicenter Study

Clinical Trial, Phase II

Case Reports

Clinical Trial

Systematic Review

Randomized Controlled Trial

Research Support, N.I.H., Extramural

Meta-Analysis

Observational Study

Clinical Trial, Phase I

Comparative Study

Practice Guideline

Network Meta-Analysis

Clinical Trial Protocol

Clinical Trial, Phase III

Research Support, N.I.H., Intramural

Consensus Development Conference

Controlled Clinical Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2005

2003

2002

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Carcinoma, Neuroendocrine""[mesh_terms]

114 Results

Searching titles within these results

Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI).

E Grande, J Santamaría Sandi, J Capdevila, E Navarro González, C Zafón Llopis, T Ramón Y Cajal Asensio, J M Gómez Sáez, P Jiménez-Fonseca, G Riesco-Eizaguirre, J C Galofré

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017;18(8):769-75

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Carcinoma, Neuroendocrine""[mesh_terms]

Consensus on management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI).

Neuroendocrine prostate cancer: subtypes, biology, and clinical outcomes.

Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta-analysis.

Calcitonin as Biomarker for the Medullary Thyroid Carcinoma.

Utilizing the circulating tumor markers in diagnosis and management of medullary thyroid cancer.

Peptide Receptor Radionuclide Therapy in Thyroid Cancer.

New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management.

Management of treatment-related toxicities in advanced medullary thyroid cancer.

Mixed glandular neuroendocrine carcinoma of the endometrium with hypercalcemic crisis.

Clinical challenges with calcitonin-negative medullary thyroid carcinoma.

Targeted systemic radiotherapy of pheochromocytoma and medullary thyroid cancer.

Esophageal Large-cell Neuroendocrine Carcinoma With Pagetoid Spread: A Case Report and Literature Review.

ENDOCAN-TUTHYREF guidelines. Locoregional therapies for locally advanced and/or metastatic thyroid cancer.

Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments.

Real-world insights into the efficacy and safety of tyrosine kinase inhibitors against thyroid cancers.

Results for
""Carcinoma, Neuroendocrine""[mesh_terms]